DD vs EDIT
Dupont De Nemours Inc (DD) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DD and EDIT stock pages for the full models.
Not investment advice.